+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

UK Artificial Tears Market 2019-2025

  • ID: 4901041
  • Report
  • January 2020
  • Region: United Kingdom
  • Orion Market Research Private Limited

FEATURED COMPANIES

  • Bausch & Lomb Inc.
  • Carl Zeiss Meditec AG
  • Essilor Group
  • Haag-Streit Group
  • Novartis International AG
  • Shire PLC
UK artificial tears market is estimated to grow considerably at a CAGR of around 5.0% during the forecast period. The eye health problems in UK have been increasing at a significant rate. According to the Royal National Institute of Blind People, more than two million people in UK live with sight losses. This includes 785,000 people having sight loss due to the uncorrected refractive error, meaning that the vision can be improved by using prescribed spectacles or contact lenses. Other causes of eye loss include age-related muscular degeneration, cataracts, glaucoma and diabetic retinopathy. The National Institute of Blind People, UK further estimates that by the end of 2030, more than 2.7 million people will have sight losses.

The market is segmented on the basis of type, delivery method, and application. Based on type, the market is divided into cellulose derived tears, glycerin derived tears and oil-based emulsion tears. On the basis of the delivery method, the market is bifurcated into artificial eye drops and ointments. Based on the application, the market is segmented into dry eye treatment, contact lenses moisture, and others. Among applications, the dry eye treatment segment holds a major share in the artificial tears market. This is mainly owing to its wide adoption in the treatment of one of the most common eye-related diseases, dry eye syndrome across the globe.

One of the key reasons which promote the growth of these surgeries is the increasing aging population in UK. According to Eurostat, the share of the old age population aging between 55-64 years in UK is expected to increase from 18.0% in 2016 to 19.4% in 2020. This is expected to increase the prevalence of eye diseases across the country, thereby promoting the growth of the market in UK. Moreover, according to the National Health Service department, in UK, 1 in every 3 people of age above 65 years is expected to suffer from dry eyes syndrome. As the share of the old age population increases, the prevalence of dry eye syndrome is also expected to increase in the coming years thereby creating opportunities for the growth of the artificial tears market over the forecast period.

The companies which are contributing to the growth of UK artificial tears market include Carl Zeiss Meditec AG, Essilor Group, Novartis International AG, Shire PLC, and Ziemer Ophthalmic Systems AG. The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, funding to the start-ups and technological advancements to stay competitive in the market.

Research Methodology

The market study of the UK artificial tears market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The research team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. the analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to the reports.

Secondary Sources Include:
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for drug manufacturers, healthcare providers, government organizations for overall market analysis, and competitive analysis. The report provides an in-depth analysis on market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation:

1. UK Artificial Tears Market Research and Analysis by Type
2. UK Artificial Tears Market Research and Analysis by Delivery Method
3. UK Artificial Tears Market Research and Analysis by Application

The Report Covers:
  • Comprehensive research methodology of the UK artificial tears market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the UK artificial tears market.
  • Insights about market determinants which are stimulating the UK artificial tears market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Bausch & Lomb Inc.
  • Carl Zeiss Meditec AG
  • Essilor Group
  • Haag-Streit Group
  • Novartis International AG
  • Shire PLC
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments

2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations

3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments

4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities

5. Market Segmentation
5.1. UK Artificial Tears Market by Type
5.1.1. Cellulose Derived Tears
5.1.2. Glycerin Derived Tears
5.1.3. Oil-Based Emulsion Tears
5.2. UK Artificial Tears Market by Delivery Method
5.2.1. Artificial Eye Drops
5.2.2. Ointments
5.3. UK Artificial Tears Market by Application
5.3.1. Dry Eyes Treatment
5.3.2. Contact Lens Moisture
5.3.3. Others

6. Company Profiles
6.1. Bausch & Lomb Inc.
6.2. Carl Zeiss Meditec AG
6.3. Essilor Group
6.4. Haag-Streit Group
6.5. Novartis International AG
6.6. Shire PLC
6.7. STAAR Surgical Co.
6.8. TopiVert Pharma Ltd.
6.9. VISUfarma B.V.
6.10. Ziemer Ophthalmic Systems AG
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Bausch & Lomb Inc.
  • Carl Zeiss Meditec AG
  • Essilor Group
  • Haag-Streit Group
  • Novartis International AG
  • Shire PLC
  • STAAR Surgical Co.
  • TopiVert Pharma Ltd.
  • VISUfarma B.V.
  • Ziemer Ophthalmic Systems AG
Note: Product cover images may vary from those shown